We are incredibly honored to have been nominated for the #PrixGalienUSA2024 “Best Biotechnology Product Award” for XACDURO®, our pathogen-targeted antibiotic against hospital-acquired and ventilator-associated bacterial pneumonia (HABP/VABP) in adults caused by Acinetobacter baumannii. Thank you to the @Galien Foundation and the award committee for recognizing our innovation and efforts to bring XACDURO to patients. #lifesciences #healthcareinnovation #biotech
Terrific, congratulations, Stephen
Congratulations!
Congrats!
Congrats!
Congrats Steve!
Agile Leader | Collaborate to Innovate | Value Creator | Change Agent | Culture Developer | BioPharma | Rare Disease | Medical Device
3moCongratulations on this incredible achievement Stephen.